Addex Spin-Out Neurosterix Begins Phase 1 Trial of...
Category : Clinical Trial Update 9 January 2026Addex Therapeutics has reached a key clinical milestone in schizophrenia drug development. Its spin-...
Clinical Trial Update
Lilly’s TOGETHER-PsA Trial Shows Dual Therapy Can...
Category : Clinical Trial Update 9 January 2026Eli Lilly has reported positive topline results from the Phase 3b TOGETHER-PsA trial, marking a firs...
Ascletis Secures FDA IND Clearance for Oral GLP-1...
Category : Clinical Trial Update 8 January 2026Ascletis Pharma has received US FDA Investigational New Drug (IND) clearance to advance ASC30, its o...
Phase III TULIP-SC Trial Confirms Subcutaneous Sap...
Category : Clinical Trial Update 8 January 2026AstraZeneca has reported positive full results from the phase III TULIP-SC trial, showing that subcu...
FDA Grants Priority Review to Tzield for Early Chi...
Category : Clinical Trial Update 7 January 2026The US FDA has moved fast. It has accepted a priority review for Sanofi’s supplemental biologi...
Latest Newsletter Post
-
Lilly’s TOGETHER-PsA Trial Shows Du..
9 January 2026
-
Muna Therapeutics Secures $1 Millio..
9 January 2026
-
Addex Spin-Out Neurosterix Begins P..
9 January 2026
-
Nimbus Therapeutics and Eli Lilly E..
9 January 2026
-
Oxeia Biopharmaceuticals Launches E..
8 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com